Johns Hopkins University, U.S.
Recent studies involving Johns Hopkins University, U.S., highlighted
Published in Hospital Business Week, May 27th, 2007
This trend article about Johns Hopkins University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New research, "Dyspnoea after antiplatelet agents: the AZD6140 controversy," is the subject of a report. "Recent randomised studies suggest that experimental oral reversible platelet P2Y12 receptor inhibitor, AZD6140, causes dyspnoea. This also raises similar concerns about the parent compound, and another adenosine triphosphate (ATP) analogue (AR-69931MX or cangrelor), which is currently in Phase 3 trial in patients undergoing coronary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Abraxis BioScience, Inc.
Abraxis BioScience Reports First Quarter 2007 Revenue of $212.2 Million Versus $144.5 Million in Prior Year Period - Air Methods Corporation
Air Methods Reports 1Q2007 Results and 2Q2007 Update - Allina Hospitals & Clinics and the University of S
Feasibility of New Medical School for Minnesota to Be Studied - Allscripts
Hutchinson Selects Allscripts Electronic Health Record and Practice Management - American Medical Alert Corp.
Walgreen Co. Gives Green Light to National Rollout of Walgreens Ready Response Medical Alert System - American Medical Student Association
AMSA Releases PharmFree Scorecard Grading Medical Schools' Policies on Pharmaceutical Company Access and Influence - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
